Abstract:Somatic cell nuclear transfer (SCNT) has been proved capable of reprogramming various differentiated somatic cells into pluripotent stem cells. Recently, induced pluripotent stem cells (iPS) have been successfully derived from mouse and human somatic cells by the over-expression of a combination of transcription factors. However, the molecular mechanisms underlying the reprogramming mediated by either the SCNT or iPS approach are poorly understood. Increasing evidence indicates that many tumor pathways play roles in the derivation of iPS cells. Embryonal carcinoma (EC) cells have the characteristics of both stem cells and cancer cells and thus they might be the better candidates for elucidating the details of the reprogramming process. Although previous studies indicate that EC cells cannot be reprogrammed into real pluripotent stem cells, the reasons for this remain unclear. Here, nuclei from mouse EC cells (P19) were transplanted into enucleated oocytes and pluripotent stem cells (P19 NTES cells) were subsequently established. Interestingly, P19 NTES cells prolonged the development of tetraploid aggregated embryos compared to EC cells alone. More importantly, we found that the expression recovery of the imprinted H19 gene was dependent on the methylation state in the differential methylation region (DMR). The induction of Nanog expression, however, was independent of the promoter region DNA methylation state in P19 NTES cells. A whole-genome transcriptome analysis further demonstrated that P19 NTES cells were indeed the intermediates between P19 cells and ES cells and many interesting genes were uncovered that may be responsible for the failed reprogramming of P19 cells. To our knowledge, for the first time, we linked incomplete reprogramming to the improved pluripotency of EC cell-derived pluripotent stem cells. The candidate genes we discovered may be useful not only for understanding the mechanisms of reprogramming, but also for deciphering the transition between tumorigenesis and pluripotency.

Effects of Reprogramming on Genomic Imprinting and the Application of Pluripotent Stem Cells

Alterations of genomic imprinting appear during the reprogramming of adult neural stem cells

Remodeling of Epigenetic Landscape During Induced Somatic Cell Reprogramming

Abnormalities in Human Pluripotent Cells Due to Reprogramming Mechanisms

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

Epigenetic and Transcriptional Shifts in Human Neural Stem Cells after Reprogramming into Induced Pluripotent Stem Cells and Subsequent Redifferentiation

Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine

Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery Behind Reprogramming

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Progress and Bottleneck in Induced Pluripotency.

Reprogramming cell fates by small molecules

Epigenetic regulation of somatic cell reprogramming

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells

Epigenetic memory in induced pluripotent stem cells

Toward pluripotency by reprogramming: mechanisms and application.

The genomic stability of induced pluripotent stem cells

Proteins Reprogramming: Present and Future.

Cellular reprogramming: a small molecule perspective.

Induced Pluripotent Stem Cell Technology in Regenerative Medicine and Biology

Molecular Mechanisms of Pluripotency and Reprogramming

Can Controlled Cellular Reprogramming Be Achieved Using Micrornas?